Clinical Trial Update: Safety and Efficacy of SRD441 Ointment in Patients With Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of SRD441 Ointment in patients with atopic dermatitis has completed, with results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• SRD441 Ointment (SRD441)

Snippet

Sponsor: Serentis Ltd. | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED